See today's BioWorld Science
To read the full story, subscribe or sign in.
Infection

Debiopharm presents new Fabl inhibitor for resistant Neisseria

May 2, 2024
Debiopharm International SA has developed and presented a Fabl inhibitor, gofabicin, for the treatment of antibiotic-resistant Neisseria gonorrhoeae.
BioWorld Science Conferences New compound European Congress of Clinical Microbiology and Infectious Diseases Infection